These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 17646546)
1. Gfi1 ubiquitination and proteasomal degradation is inhibited by the ubiquitin ligase Triad1. Marteijn JA; van der Meer LT; van Emst L; van Reijmersdal S; Wissink W; de Witte T; Jansen JH; Van der Reijden BA Blood; 2007 Nov; 110(9):3128-35. PubMed ID: 17646546 [TBL] [Abstract][Full Text] [Related]
2. The ubiquitin ligase Triad1 inhibits myelopoiesis through UbcH7 and Ubc13 interacting domains. Marteijn JA; van der Meer LT; Smit JJ; Noordermeer SM; Wissink W; Jansen P; Swarts HG; Hibbert RG; de Witte T; Sixma TK; Jansen JH; van der Reijden BA Leukemia; 2009 Aug; 23(8):1480-9. PubMed ID: 19340006 [TBL] [Abstract][Full Text] [Related]
3. Diminished proteasomal degradation results in accumulation of Gfi1 protein in monocytes. Marteijn JA; van der Meer LT; Van Emst L; de Witte T; Jansen JH; van der Reijden BA Blood; 2007 Jan; 109(1):100-8. PubMed ID: 16888099 [TBL] [Abstract][Full Text] [Related]
4. The E3 ubiquitin-protein ligase Triad1 inhibits clonogenic growth of primary myeloid progenitor cells. Marteijn JA; van Emst L; Erpelinck-Verschueren CA; Nikoloski G; Menke A; de Witte T; Löwenberg B; Jansen JH; van der Reijden BA Blood; 2005 Dec; 106(13):4114-23. PubMed ID: 16118314 [TBL] [Abstract][Full Text] [Related]
5. TRIAD1 is negatively regulated by the MDM2 E3 ligase. Bae S; Jung JH; An IS; Kim OY; Lee MJ; Lee JH; Park IC; Lee SJ; An S Oncol Rep; 2012 Nov; 28(5):1924-8. PubMed ID: 22940738 [TBL] [Abstract][Full Text] [Related]
7. The E3 ubiquitin-ligase Bmi1/Ring1A controls the proteasomal degradation of Top2alpha cleavage complex - a potentially new drug target. Alchanati I; Teicher C; Cohen G; Shemesh V; Barr HM; Nakache P; Ben-Avraham D; Idelevich A; Angel I; Livnah N; Tuvia S; Reiss Y; Taglicht D; Erez O PLoS One; 2009 Dec; 4(12):e8104. PubMed ID: 19956605 [TBL] [Abstract][Full Text] [Related]
8. UHRF2, a ubiquitin E3 ligase, acts as a small ubiquitin-like modifier E3 ligase for zinc finger protein 131. Oh Y; Chung KC J Biol Chem; 2013 Mar; 288(13):9102-11. PubMed ID: 23404503 [TBL] [Abstract][Full Text] [Related]
9. UFD2a mediates the proteasomal turnover of p73 without promoting p73 ubiquitination. Hosoda M; Ozaki T; Miyazaki K; Hayashi S; Furuya K; Watanabe K; Nakagawa T; Hanamoto T; Todo S; Nakagawara A Oncogene; 2005 Nov; 24(48):7156-69. PubMed ID: 16170377 [TBL] [Abstract][Full Text] [Related]
10. Ubiquitin ligase Triad1 promotes neurite outgrowth by inhibiting MDM2-mediated ubiquitination of the neuroprotective factor pleiotrophin. Wu C; Xu G; Bao G; Gao H; Chen J; Zhang J; Chen C; Hong H; Xue P; Jiang J; Liu Y; Huang J; Sun Y; Fu J; Li Y; Cui Z J Biol Chem; 2022 Oct; 298(10):102443. PubMed ID: 36055408 [TBL] [Abstract][Full Text] [Related]
11. The E3 ubiquitin ligase HECW1 targets thyroid transcription factor 1 (TTF1/NKX2.1) for its degradation in the ubiquitin-proteasome system. Liu J; Dong S; Li L; Wang H; Zhao J; Zhao Y Cell Signal; 2019 Jun; 58():91-98. PubMed ID: 30849519 [TBL] [Abstract][Full Text] [Related]
14. The E3 ubiquitin ligase CHIP mediates ubiquitination and proteasomal degradation of PRMT5. Zhang HT; Zeng LF; He QY; Tao WA; Zha ZG; Hu CD Biochim Biophys Acta; 2016 Feb; 1863(2):335-46. PubMed ID: 26658161 [TBL] [Abstract][Full Text] [Related]
15. SUMOylation Regulates Growth Factor Independence 1 in Transcriptional Control and Hematopoiesis. Andrade D; Velinder M; Singer J; Maese L; Bareyan D; Nguyen H; Chandrasekharan MB; Lucente H; McClellan D; Jones D; Sharma S; Liu F; Engel ME Mol Cell Biol; 2016 May; 36(10):1438-50. PubMed ID: 26951200 [TBL] [Abstract][Full Text] [Related]
16. ZSCAN4 is negatively regulated by the ubiquitin-proteasome system and the E3 ubiquitin ligase RNF20. Portney BA; Khatri R; Meltzer WA; Mariano JM; Zalzman M Biochem Biophys Res Commun; 2018 Mar; 498(1):72-78. PubMed ID: 29477841 [TBL] [Abstract][Full Text] [Related]
17. TRIAD1 inhibits MDM2-mediated p53 ubiquitination and degradation. Bae S; Jung JH; Kim K; An IS; Kim SY; Lee JH; Park IC; Jin YW; Lee SJ; An S FEBS Lett; 2012 Sep; 586(19):3057-63. PubMed ID: 22819825 [TBL] [Abstract][Full Text] [Related]